Cymbalta
Product Images NDC 21695-657

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cymbalta (NDC 21695-657). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (7db112de 473a 4407 Bc1c 35d0ab748700 01)

Chemical structure of Duloxetine hydrochloride shown as a 2D molecular diagram with functional groups including a naphthalene ring, thiophene ring, and amine hydrochloride group. This corresponds to the active ingredient in Cymbalta by Rebel Distributors Corp.*

FDA Label Image

Figure 1 (7db112de 473a 4407 Bc1c 35d0ab748700 02)

A line chart showing the percentage of patients improved plotted against percent improvement in pain from baseline for Cymbalta at 60 mg twice daily, 60 mg once daily, 20 mg once daily, and placebo. The graph compares the effectiveness of different Cymbalta dosages versus placebo in pain improvement.*

FDA Label Image

Figure 2 (7db112de 473a 4407 Bc1c 35d0ab748700 03)

A line graph depicting the percentage of patients improved against the percent improvement in pain from baseline for three groups: CYM 60mg BID, CYM 60mg QD, and placebo. The graph tracks improvement levels from 0% to 100%, showing comparative patient response rates for each treatment and placebo over increasing pain improvement percentages.*

FDA Label Image

Figure 3 (7db112de 473a 4407 Bc1c 35d0ab748700 04)

A line graph depicting the percentage of patients improved relative to percent improvement in pain from baseline for three groups: CYM 60 mg twice daily, CYM 60 mg once daily, and placebo. The x-axis represents percent improvement in pain, and the y-axis shows the percentage of patients improved. The graph shows higher patient improvement percentages for both CYM doses compared to placebo across most pain improvement levels.*

FDA Label Image

Figure 4 (7db112de 473a 4407 Bc1c 35d0ab748700 05)

A line graph showing the percentage of patients improved versus percent improvement in pain from baseline for Cymbalta (CYM) doses 20 mg, 60 mg, and 120 mg once daily compared to placebo. The graph shows decreasing patient improvement percentages as percent pain improvement increases, with placebo consistently lower than all Cymbalta doses.*

FDA Label Image

Figure 5 (7db112de 473a 4407 Bc1c 35d0ab748700 06)

A line graph comparing the percentage of patients improved based on percent improvement in pain from baseline for two groups: placebo and CYM60/120 mg once daily. The x-axis represents percent improvement in pain from baseline, and the y-axis represents the percentage of patients improved. CYM60/120 mg shows a higher percentage of patients improved across most levels of pain improvement compared to placebo.*

FDA Label Image

Figure 6 (7db112de 473a 4407 Bc1c 35d0ab748700 07)

A line graph comparing percentage of patients improved based on percent improvement in pain from baseline between placebo and Cymbalta (60 mg once daily). The graph shows higher percentages of patient improvement with Cymbalta across various improvement thresholds from greater than 0% to 100%.*

FDA Label Image

Figure 7 (7db112de 473a 4407 Bc1c 35d0ab748700 08)

A line graph comparing the percentage of patients improved against the percent improvement in pain from baseline (BOCF). It includes two data series: Placebo and CYM60/120 mg once daily, showing the trend of patient improvement in pain for each treatment.*

FDA Label Image

Cymbalta 20mg (7db112de 473a 4407 Bc1c 35d0ab748700 09)

Label for Cymbalta 20 mg DR Capsules, bottle quantity 60, distributed by Physician Partner and manufactured by Eli Lilly and Company, Indianapolis, IN. The label includes dosage strength, active ingredient amount per capsule, NDC 21695-657-60, lot number, expiration date placeholders, and storage conditions. The label also notes the capsule's appearance and imprint details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.